Co-delivery of paclitaxel with MDR1-targeting siRNA using biodegradable polymeric NPs significantly increased the cytotoxic effect of paclitaxel in drug-resistant ovarian cancer cells, effectively restoring sensitivity to a level comparable with drug-sensitive cells [206]. The gene discussed is ABCB1; the disease is ovarian carcinoma.